Literature DB >> 33471285

Mutational Impact on "in-Between-Ring" (IBR) Domain of PARKIN on Protein Stability and Function.

Sima Biswas1, Angshuman Bagchi2.   

Abstract

Mutations in parkin, which is encoded by the PARK2 gene, are associated with a rare form of Parkinson's disease called autosomal recessive juvenile parkinsonism (ARJP). Parkin is a member of RBR family of E3 ubiquitin ligase. Parkin contains a RING1-In-Between-Ring (IBR)-RING2 motif. The IBR domain is located at the C-terminal end of the parkin protein. Two zinc-binding sites are present in the IBR domain which shows zinc ion-dependent folding and maintains the orientation and geometry of RING domains. So, mutation in a zinc-binding region can be responsible for improper folding of parkin protein, which eventually affects the protein structure and function. Abnormalities in parkin protein increase the aggregation of mis-folded proteins in the brain cell. As a consequence, cellular toxicity occurs. The IBR domain also interacts with UbcH7 and UbcH8 proteins belonging to E2 protein family and facilitates synphilin-1, Sept5, and SIM2 protein ubiquitination. It is reported that missense mutation in parkin protein are responsible for autosomal recessive juvenile Parkinson disease. In this work, we first collected the missense mutations in the IBR domain from literature and sequence databases. Then, using various computational tools, we predicted their pathogenicity and involvements in causing possible changes in various protein properties. Evolutionary conservation of amino acids, solvent accessible surface areas, the physico-chemical properties, and changes of protein structure were analyzed. We, for the first time, analyzed the effects of these mutations in parkin to decipher the plausible molecular mechanism of Parkinson's disease.

Entities:  

Keywords:  IBR domain; Mutation; Neurodegenerative disease; PARK2; Parkin; Zinc binding

Mesh:

Substances:

Year:  2021        PMID: 33471285     DOI: 10.1007/s12010-021-03491-2

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  10 in total

1.  Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival.

Authors:  Calvin W S Yeo; Felicia S L Ng; Chou Chai; Jeanne M M Tan; Geraldene R H Koh; Yuk Kien Chong; Lynnette W H Koh; Charlene S F Foong; Edwin Sandanaraj; Joanna D Holbrook; Beng-Ti Ang; Ryosuke Takahashi; Carol Tang; Kah-Leong Lim
Journal:  Cancer Res       Date:  2012-03-19       Impact factor: 12.701

2.  Parkin function in Parkinson's disease.

Authors:  Connor Arkinson; Helen Walden
Journal:  Science       Date:  2018-04-20       Impact factor: 47.728

3.  Parkinson's Disease: A Review from Pathophysiology to Treatment.

Authors:  Bianca L B Marino; Lucilene R de Souza; Kessia P A Sousa; Jaderson V Ferreira; Elias C Padilha; Carlos H T P da Silva; Carlton A Taft; Lorane I S Hage-Melim
Journal:  Mini Rev Med Chem       Date:  2020       Impact factor: 3.862

4.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

5.  An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene.

Authors:  S Hayashi; K Wakabayashi; A Ishikawa; H Nagai; M Saito; M Maruyama; T Takahashi; T Ozawa; S Tsuji; H Takahashi
Journal:  Mov Disord       Date:  2000-09       Impact factor: 10.338

Review 6.  Parkinson's disease: clinical aspects.

Authors:  Thomas Klockgether
Journal:  Cell Tissue Res       Date:  2004-09-08       Impact factor: 5.249

7.  Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection.

Authors:  Jean-François Trempe; Edward A Fon
Journal:  Front Neurol       Date:  2013-04-19       Impact factor: 4.003

8.  Impact of autosomal recessive juvenile Parkinson's disease mutations on the structure and interactions of the parkin ubiquitin-like domain.

Authors:  Susan S Safadi; Kathryn R Barber; Gary S Shaw
Journal:  Biochemistry       Date:  2011-03-09       Impact factor: 3.162

9.  Improving the prediction of disease-related variants using protein three-dimensional structure.

Authors:  Emidio Capriotti; Russ B Altman
Journal:  BMC Bioinformatics       Date:  2011-07-05       Impact factor: 3.169

Review 10.  Parkin structure and function.

Authors:  Marjan Seirafi; Guennadi Kozlov; Kalle Gehring
Journal:  FEBS J       Date:  2015-03-16       Impact factor: 5.542

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.